Japan Names New Health Vice-Minister

2 December 1996

Takehiko Yamaguchi, head of the Japanese Ministry of Health and Welfare's Health Insurance Bureau,has been named Health Vice-Minister in succession to Nobuhara Okamitsu,who has resigned over allegations that he improperly received favors from the operator of a chain of nursing homes (Marketletter November 25),

Mr Okamitsu continues to deny wrong-doing. He is quoted as saying the claims are untrue, and that he will prepare documents to defend himself. Hiroshi Koyama, who was arrested on November 18 for bribing a former MHW official, says he paid Mr Okamitsu 60 million yen ($537,900) and also provided other favors. Other MHW officials are being investigated in connection with this case.

In another unrelated bribery case, Japanese police have arrested Ryuji Kaji, a lecturer at Kyoto University Hospital, for accepting money from Allergan KK in connection with clinical trials for a drug to treat dystonia. Mr Kaji denies charges that he provided favorable results for the drug in order to accelerate the approval process, although two of the three Allergan employees who were also arrested have admitted to the bribery charges.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight